Marine Compounds and Cancer: 2017 Updates

Standard

Marine Compounds and Cancer: 2017 Updates. / Dyshlovoy, Sergey A; Honecker, Friedemann.

in: MAR DRUGS, Jahrgang 16, Nr. 2, 24.01.2018, S. 41.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungAndere (Vorworte u.ä.)Forschung

Harvard

APA

Vancouver

Bibtex

@article{be5af94833d14b46a6a9f2ec4cdc5d6b,
title = "Marine Compounds and Cancer: 2017 Updates",
abstract = "By the end of 2017, there were seven marine-derived pharmaceutical substances that have been approved by the FDA for clinical use as drugs[...].",
keywords = "Animals, Antineoplastic Agents, Humans, Marine Toxins, Neoplasms, Periodicals as Topic, Editorial",
author = "Dyshlovoy, {Sergey A} and Friedemann Honecker",
note = "Document Type: Editorial Material",
year = "2018",
month = jan,
day = "24",
doi = "10.3390/md16020041",
language = "English",
volume = "16",
pages = "41",
journal = "MAR DRUGS",
issn = "1660-3397",
publisher = "MDPI AG",
number = "2",

}

RIS

TY - JOUR

T1 - Marine Compounds and Cancer: 2017 Updates

AU - Dyshlovoy, Sergey A

AU - Honecker, Friedemann

N1 - Document Type: Editorial Material

PY - 2018/1/24

Y1 - 2018/1/24

N2 - By the end of 2017, there were seven marine-derived pharmaceutical substances that have been approved by the FDA for clinical use as drugs[...].

AB - By the end of 2017, there were seven marine-derived pharmaceutical substances that have been approved by the FDA for clinical use as drugs[...].

KW - Animals

KW - Antineoplastic Agents

KW - Humans

KW - Marine Toxins

KW - Neoplasms

KW - Periodicals as Topic

KW - Editorial

U2 - 10.3390/md16020041

DO - 10.3390/md16020041

M3 - Other (editorial matter etc.)

C2 - 29364147

VL - 16

SP - 41

JO - MAR DRUGS

JF - MAR DRUGS

SN - 1660-3397

IS - 2

ER -